JPWO2023164696A5 - - Google Patents

Info

Publication number
JPWO2023164696A5
JPWO2023164696A5 JP2024550753A JP2024550753A JPWO2023164696A5 JP WO2023164696 A5 JPWO2023164696 A5 JP WO2023164696A5 JP 2024550753 A JP2024550753 A JP 2024550753A JP 2024550753 A JP2024550753 A JP 2024550753A JP WO2023164696 A5 JPWO2023164696 A5 JP WO2023164696A5
Authority
JP
Japan
Prior art keywords
modified oligonucleotide
modified
internucleoside linkage
optionally
sugar moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024550753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507749A5 (https=
JP2025507749A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/063353 external-priority patent/WO2023164696A2/en
Publication of JP2025507749A publication Critical patent/JP2025507749A/ja
Publication of JP2025507749A5 publication Critical patent/JP2025507749A5/ja
Publication of JPWO2023164696A5 publication Critical patent/JPWO2023164696A5/ja
Pending legal-status Critical Current

Links

JP2024550753A 2022-02-28 2023-02-27 プリオン発現のＲＮＡｉ剤 Pending JP2025507749A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263314800P 2022-02-28 2022-02-28
US63/314,800 2022-02-28
PCT/US2023/063353 WO2023164696A2 (en) 2022-02-28 2023-02-27 Rnai agents of prion expression

Publications (3)

Publication Number Publication Date
JP2025507749A JP2025507749A (ja) 2025-03-21
JP2025507749A5 JP2025507749A5 (https=) 2026-03-10
JPWO2023164696A5 true JPWO2023164696A5 (https=) 2026-03-10

Family

ID=87766801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024550753A Pending JP2025507749A (ja) 2022-02-28 2023-02-27 プリオン発現のＲＮＡｉ剤

Country Status (4)

Country Link
US (1) US20260028623A1 (https=)
EP (1) EP4486892A2 (https=)
JP (1) JP2025507749A (https=)
WO (1) WO2023164696A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202103794QA (en) 2018-11-21 2021-05-28 Ionis Pharmaceuticals Inc Compounds and methods for reducing prion expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225922A1 (en) * 2011-03-04 2012-09-06 Qr Pharma Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
SG11202103794QA (en) * 2018-11-21 2021-05-28 Ionis Pharmaceuticals Inc Compounds and methods for reducing prion expression

Similar Documents

Publication Publication Date Title
CN110079524B (zh) 用于调节hbv和ttr表达的组合物和方法
JP7557469B2 (ja) Ａｐｐの発現を低減するための化合物及び方法
JP7535047B2 (ja) トリループを含む二本鎖核酸インヒビター分子
JPWO2020132227A5 (https=)
JPH08502723A (ja) オリゴヌクレオチド・アルキルホスホノチオエート
CA3094008A1 (en) Double-stranded nucleic acid inhibitor molecules modified with tm-increasing nucleotides
JP2024523363A (ja) Ｉｆｎａｒ１の発現を低減するための化合物及び方法
CA3210172A1 (en) Compounds and methods for reducing pln expression
US12529053B2 (en) Double-stranded nucleic acid inhibitor molecules with shortened sense strands
JPWO2020160163A5 (https=)
JPWO2023064707A5 (https=)
JPWO2023164696A5 (https=)
JPWO2022271786A5 (https=)
JPWO2022159712A5 (https=)
JPWO2021258011A5 (https=)
JPWO2021119226A5 (https=)
WO2024040041A1 (en) Regulation of activity of rnai molecules
JPWO2021252799A5 (https=)
EP4402260A1 (en) Compounds and methods for reducing dnm1l or drp1 expression
JPWO2020190740A5 (https=)
JPWO2022072787A5 (https=)
JPWO2022032060A5 (https=)
JPWO2020132558A5 (https=)
JPWO2022066956A5 (https=)
JPWO2022266415A5 (https=)